Manasanch EE, Han G, Mathur R, et al. A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysis. Blood Adv. 2019;3(15):2400-2408.
Jazyk: | angličtina |
---|---|
Zdroj: | Blood advances [Blood Adv] 2019 Sep 24; Vol. 3 (18), pp. 2712. |
DOI: | 10.1182/bloodadvances.2019000881 |
Databáze: | MEDLINE |
Externí odkaz: |